Alterity Therapeutics (ATHE) Non-Current Assets (2009 - 2025)

Alterity Therapeutics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $62953.8 for Q4 2025.

• On a quarterly basis, Non-Current Assets fell 16.83% year-over-year to $62953.8 in Q4 2025; TTM through Dec 2025 was $361189.0, a 8.99% increase from a year earlier, with the FY2025 full-year figure at $99378.6, down 19.31% from the prior year.
• Non-Current Assets slipped to $62953.8 in Q4 2025 per ATHE's latest filing, from $99378.6 in the prior quarter.
• Across five years, Non-Current Assets topped out at $156520.4 in Q2 2022 and bottomed at $2688.6 in Q2 2023.
• The 5-year median for Non-Current Assets is $87537.4 (2024), against an average of $88931.2.
• Across the five-year window, Non-Current Assets plunged 98.28% in 2023 and jumped 4480.79% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $49763.2 in 2021, then surged by 130.58% to $114742.3 in 2022, then gained by 13.18% to $129861.5 in 2023, then sank by 41.71% to $75696.1 in 2024, then slipped by 16.83% to $62953.8 in 2025.
• Per Business Quant, the three latest ATHE Non-Current Assets figures stand at $62953.8 (Q4 2025), $99378.6 (Q2 2025), and $75696.1 (Q4 2024).